G01N 2410/02
Angiotensins
Official title: Angiotensins; Related peptides
G01N2410/02 (Angiotensins) appears on 17 US grants and 28 published applications in this corpus.
Search patents in G01N- Granted patents
- 17
- Published applications
- 28
- Assignees
- 22
- Inventors
- 52
- Latest grant
- 21 Feb 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 2 | 2 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 2 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 2 |
| 2016 | 3 | 5 |
| 2017 | 2 | 3 |
| 2018 | 0 | 1 |
| 2019 | 2 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 3 |
| 2022 | 1 | 0 |
| 2023 | 1 | 2 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods for administering angiotensin II21 Feb 2023US 11,583,568 B2La Jolla Pharma, LLC
- Methods for treating hypotension in a patient that has received an ACE inhibitor by administering angiotensin II11 Jan 2022US 11,219,662 B2La Jolla Pharma, LLC
- Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples3 Aug 2021US 11,079,398 B2Attoquant Diagnostics GmbH
- Methods for administering angiotensin II10 Sep 2019US 10,406,201 B2La Jolla Pharma, LLC
- Method for diagnosis of primary hyperaldosteronism21 May 2019US 10,295,552 B2Attoquant Diagnostics GmbH
- Covid-19 theranostic23 Jan 2025US 2025/0027942 A1Universite Libre de Bruxelles
- Screening kit and diagnosis system for primary aldosteronism4 Apr 2024US 2024/0110929 A1Hangzhou Calibra Diagnostics Co., Ltd.
- Renin-based analysis of hepcidin12 Oct 2023US 2023/0324413 A1Tampere University Foundation sr
- Methods of Detecting and Treating Immune Responses Associated with Viral Infection15 Jun 2023US 2023/0184786 A1Forsyth Dental Infirmary for Children (D/B/A the Forsyth Institute)
- Dysregulation of covid-19 receptor associated with ibd28 Oct 2021US 2021/0332122 A1Cedars-Sinai Medical Center
Most cited
By later US patents
- Isoelectric point markers for isoelectric focusing with fluorescence detection17US 5,866,683 ALaboratory of Molecular Biophotonics · 1999
- Device and methods for the immunological identification of cerebrospinal fluid10US 9,347,955 B2Affinimark Technologies, Inc., · 2016
- Angiotensin IV and analogs as regulators of fibrinolysis6US 5,599,663 ABrighan & Women's Hospital · 1997
- Device and methods for the immunological identification of cerebrospinal fluid3US 8,445,218 B2Affinimark Technologies, Inc., · 2013
- Methods for administering angiotensin II2US 10,406,201 B2La Jolla Pharma, LLC · 2019